Matsunaga R, Tsumoto K
Protein Sci. 2025; 34(3):e70065.
PMID: 39981938
PMC: 11843469.
DOI: 10.1002/pro.70065.
Yu R, Zhang L, Bai Y, Zhou P, Yang J, Wang D
J Clin Microbiol. 2025; 63(3):e0161524.
PMID: 39950715
PMC: 11898664.
DOI: 10.1128/jcm.01615-24.
Liu J, Wu L, Xie A, Liu W, He Z, Wan Y
J Nanobiotechnology. 2025; 23(1):87.
PMID: 39915791
PMC: 11800653.
DOI: 10.1186/s12951-025-03169-5.
Chen Z, Huang H, Wang X, Schon K, Jia Y, Lebens M
Nat Commun. 2025; 16(1):432.
PMID: 39788944
PMC: 11718266.
DOI: 10.1038/s41467-024-55193-y.
Amesaka H, Tachibana M, Hara M, Toya S, Nakagawa H, Matsumura H
Protein Sci. 2024; 34(1):e70018.
PMID: 39724358
PMC: 11670304.
DOI: 10.1002/pro.70018.
Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years.
Alexander E, Leong K
J Nanobiotechnology. 2024; 22(1):661.
PMID: 39455963
PMC: 11515141.
DOI: 10.1186/s12951-024-02900-y.
Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist.
Fontaine T, Busch A, Laeremans T, De Cesco S, Liang Y, Jaakola V
Nat Commun. 2024; 15(1):7029.
PMID: 39353917
PMC: 11445563.
DOI: 10.1038/s41467-024-50827-7.
Functional Divergence in the Affinity and Stability of Non-Canonical Cysteines and Non-Canonical Disulfide Bonds: Insights from a VHH and VNAR Study.
Xu M, Zhao Z, Deng P, Sun M, Chiu C, Wu Y
Int J Mol Sci. 2024; 25(18).
PMID: 39337289
PMC: 11432006.
DOI: 10.3390/ijms25189801.
Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation.
Sun L, Chen B, Liu X, Zhu Y, Zhang G, Liang X
Curr Res Microb Sci. 2024; 7:100263.
PMID: 39176008
PMC: 11339056.
DOI: 10.1016/j.crmicr.2024.100263.
Development of novel humanized VHH synthetic libraries based on physicochemical analyses.
Nakakido M, Kinoshita S, Tsumoto K
Sci Rep. 2024; 14(1):19533.
PMID: 39174623
PMC: 11341556.
DOI: 10.1038/s41598-024-70513-4.
Scalable, robust, high-throughput expression & purification of nanobodies enabled by 2-stage dynamic control.
Hennigan J, Menacho-Melgar R, Sarkar P, Golovsky M, Lynch M
Metab Eng. 2024; 85:116-130.
PMID: 39059674
PMC: 11408108.
DOI: 10.1016/j.ymben.2024.07.012.
Allosteric nanobodies to study the interactions between SOS1 and RAS.
Fischer B, Uchanski T, Sheryazdanova A, Gonzalez S, Volkov A, Brosens E
Nat Commun. 2024; 15(1):6214.
PMID: 39043660
PMC: 11266648.
DOI: 10.1038/s41467-024-50349-2.
Single-domain antibodies as therapeutics for solid tumor treatment.
Wang M, Ying T, Wu Y
Acta Pharm Sin B. 2024; 14(7):2854-2868.
PMID: 39027249
PMC: 11252471.
DOI: 10.1016/j.apsb.2024.03.016.
Phage display-derived alpaca nanobodies as potential therapeutics for snake envenomation.
Wang W, Chang J, Lee C, Chiang Y, Leu S, Mao Y
Appl Environ Microbiol. 2024; 90(8):e0012124.
PMID: 38980046
PMC: 11337809.
DOI: 10.1128/aem.00121-24.
A Nanobody/Monoclonal Antibody "hybrid" sandwich technology offers an improved immunoassay strategy for detection of African trypanosome infections.
Odongo S, Jin B, Nguyen H, Radwanska M, Magez S
PLoS Negl Trop Dis. 2024; 18(7):e0012294.
PMID: 38950072
PMC: 11244815.
DOI: 10.1371/journal.pntd.0012294.
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications.
El Salamouni N, Cater J, Spenkelink L, Yu H
FEBS Open Bio. 2024; 15(2):236-253.
PMID: 38898362
PMC: 11788755.
DOI: 10.1002/2211-5463.13850.
A novel sustainable immunoassay for sensitive detection of atrazine based on the anti-idiotypic nanobody and recombinant full-length antibody.
Zhao J, Li P, Abd El-Aty A, Xu L, Lei X, Gao S
Chem Eng J. 2024; 491.
PMID: 38882000
PMC: 11173377.
DOI: 10.1016/j.cej.2024.152039.
Single domain antibodies from camelids in the treatment of microbial infections.
De Greve H, Fioravanti A
Front Immunol. 2024; 15:1334829.
PMID: 38827746
PMC: 11140111.
DOI: 10.3389/fimmu.2024.1334829.
Structural basis for selectivity and antagonism in extracellular GPCR-nanobodies.
Schlimgen R, Peterson F, Heukers R, Smit M, McCorvy J, Volkman B
Nat Commun. 2024; 15(1):4611.
PMID: 38816420
PMC: 11139983.
DOI: 10.1038/s41467-024-49000-x.
Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.
Jiang Y, Wang R, Guo J, Cheng K, Chen L, Wang X
Front Immunol. 2024; 15:1380694.
PMID: 38779676
PMC: 11109933.
DOI: 10.3389/fimmu.2024.1380694.